169 related articles for article (PubMed ID: 38397086)
1. A Cross-Sectional Study of Protein Changes Associated with Dementia in Non-Obese Weight Matched Women with and without Polycystic Ovary Syndrome.
Butler AE; Moin ASM; Sathyapalan T; Atkin SL
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397086
[TBL] [Abstract][Full Text] [Related]
2. A Cross-Sectional Study of Alzheimer-Related Proteins in Women with Polycystic Ovary Syndrome.
Butler AE; Moin ASM; Sathyapalan T; Atkin SL
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256230
[TBL] [Abstract][Full Text] [Related]
3. Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity.
Moin ASM; Sathyapalan T; Butler AE; Atkin SL
Clin Endocrinol (Oxf); 2023 Jun; 98(6):796-802. PubMed ID: 36859809
[TBL] [Abstract][Full Text] [Related]
4. High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome.
Butler AE; Moin ASM; Reiner Ž; Sathyapalan T; Jamialahmadi T; Sahebkar A; Atkin SL
Front Endocrinol (Lausanne); 2023; 14():1117761. PubMed ID: 37181037
[TBL] [Abstract][Full Text] [Related]
5. Effects of apolipoprotein E genotypes on metabolic profile and oxidative stress in southwest Chinese women with polycystic ovary syndrome.
Liu HW; Zhang F; Fan P; Bai H; Zhang JX; Wang Y
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):146-51. PubMed ID: 23746632
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Markers in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D Metabolites.
Moin ASM; Sathyapalan T; Atkin SL; Butler AE
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079796
[TBL] [Abstract][Full Text] [Related]
7. Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D.
Moin ASM; Sathyapalan T; Butler AE; Atkin SL
Front Endocrinol (Lausanne); 2022; 13():935750. PubMed ID: 36619572
[TBL] [Abstract][Full Text] [Related]
8. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D.
Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
10. Alterations in plasma non-esterified fatty acid (NEFA) kinetics and relationship with insulin resistance in polycystic ovary syndrome.
Ezeh U; Arzumanyan Z; Lizneva D; Mathur R; Chen YH; Boston RC; Chen YI; Azziz R
Hum Reprod; 2019 Feb; 34(2):335-344. PubMed ID: 30576500
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
12. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes.
Aziz M; Sidelmann JJ; Faber J; Wissing ML; Naver KV; Mikkelsen AL; Nilas L; Skouby SO
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1082-9. PubMed ID: 26123797
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL₂ and HDL₃.
Gidwani S; Phelan N; McGill J; McGowan A; O'Connor A; Young IS; Gibney J; McEneny J
Hum Reprod; 2014 Jul; 29(7):1518-25. PubMed ID: 24842896
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA expression in non-obese women with polycystic ovary syndrome and weight-matched controls.
Butler AE; Hayat S; Dargham SR; Malek JA; Abdullah SA; Mahmoud YA; Sathyapalan T; Atkin SL
Reprod Biomed Online; 2020 Oct; 41(4):579-583. PubMed ID: 32819839
[TBL] [Abstract][Full Text] [Related]
16. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
17. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
18. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
[TBL] [Abstract][Full Text] [Related]
19. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
[TBL] [Abstract][Full Text] [Related]
20. Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents With Polycystic Ovary Syndrome.
Vine DF; Wang Y; Jetha MM; Ball GD; Proctor SD
J Clin Endocrinol Metab; 2017 Mar; 102(3):970-982. PubMed ID: 27997268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
